19 Scopus citations


Much progress had been made during the last decade in the use of high- dose chemotherapy and autologous bone marrow transplantation (ABMT) for lymphoid malignancies; however, the most optimal timing, best preparative regimen, and best hematopoietic rescue source for transplantation have not been identified. This article outlines various studies using high-dose therapy and ABMT for lymphoid malignancies at institutions throughout the world. Furthermore, the use of alternative hematopoietic sources such as autologous peripheral stem cells and the use of hematopoietic growth factors with transplantation for non-Hodgkin's lymphomas also are discussed.

Original languageEnglish (US)
Pages (from-to)577-590
Number of pages14
JournalHematology/Oncology Clinics of North America
Issue number3
StatePublished - Jan 1 1993


ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this